Technology
Health
Biotechnology
Chimerix
$3.539876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$3.53
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.10 (-2.75%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours
Why Robinhood?
You can buy or sell Chimerix and other stocks, options, ETFs, and crypto commission-free!
About CMRX
Chimerix, Inc. Common Stock, also called Chimerix, is a biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceutical products. Read More Its portfolio includes Brincidofovir for the treatment of adenovirus, cytomegalovirus, and smallpox. The company was founded by George R. Painter, III and Timothy Wollaeger in April 2000 and is headquartered in Durham, NC.
Employees
59
Headquarters
Durham, North Carolina
Founded
2000
Market Cap
185.22M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
270.50K
High Today
$3.64
Low Today
$3.47
Open Price
$3.64
Volume
226.10K
52 Week High
$4.63
52 Week Low
$1.74
Collections
Technology
Health
Biotechnology
Biopharmaceutical
Pharmaceutical
2013 IPO
US
North America
Price Paid on Robinhood
16% Lower
Right Now
52 Week Low
$1.74
Average Price Paid
$4.20
52 Week High
$4.63
CMRX Earnings
-$0.47
-$0.41
-$0.35
-$0.29
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
Expected Aug 8, Pre-Market